What are the adverse drug reactions of atogepant (Qulipta)?

Prepare for the Pharmacology IV – Headache Therapeutics Test. Review the therapeutic approaches, tackle multiple-choice questions with explanations, and boost your test-taking confidence. Ace your exam with precision!

Multiple Choice

What are the adverse drug reactions of atogepant (Qulipta)?

Atogepant’s adverse effects reflect CGRP pathway blockade, which can influence both gut motility and CNS symptoms. The most consistently reported side effects are constipation, nausea, and fatigue or sleepiness. Constipation occurs from slowed intestinal transit linked to CGRP inhibition; nausea is a common GI response, and fatigue or somnolence likely stems from central nervous system effects. While dizziness or headache can occur with migraine therapies, they are not as characteristic of atogepant as the trio above, and nausea alone doesn’t capture the full ADR pattern. For management, stay hydrated, maintain fiber intake, and monitor constipation—dose adjustments may be needed if symptoms are persistent or troublesome.

Atogepant’s adverse effects reflect CGRP pathway blockade, which can influence both gut motility and CNS symptoms. The most consistently reported side effects are constipation, nausea, and fatigue or sleepiness. Constipation occurs from slowed intestinal transit linked to CGRP inhibition; nausea is a common GI response, and fatigue or somnolence likely stems from central nervous system effects. While dizziness or headache can occur with migraine therapies, they are not as characteristic of atogepant as the trio above, and nausea alone doesn’t capture the full ADR pattern. For management, stay hydrated, maintain fiber intake, and monitor constipation—dose adjustments may be needed if symptoms are persistent or troublesome.

More practice questions